Global Familial Adenomatous Polyposis Treatment Market Research Report 2023

The global Familial Adenomatous Polyposis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Familial Adenomatous Polyposis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Familial Adenomatous Polyposis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Familial Adenomatous Polyposis Treatment in Clinic is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Familial Adenomatous Polyposis Treatment include Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc and Thetis Pharmaceuticals LLC, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Familial Adenomatous Polyposis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Familial Adenomatous Polyposis Treatment.

The Familial Adenomatous Polyposis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Familial Adenomatous Polyposis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Familial Adenomatous Polyposis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Icosapent

1.2.3 Eflornithine Hydrochloride

1.2.4 Aspirin

1.2.5 CEQ-508

1.2.6 Others

1.3 Market by Application

1.3.1 Global Familial Adenomatous Polyposis Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Familial Adenomatous Polyposis Treatment Market Perspective (2018-2029)

2.2 Familial Adenomatous Polyposis Treatment Growth Trends by Region

2.2.1 Global Familial Adenomatous Polyposis Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Familial Adenomatous Polyposis Treatment Historic Market Size by Region (2018-2023)

2.2.3 Familial Adenomatous Polyposis Treatment Forecasted Market Size by Region (2024-2029)

2.3 Familial Adenomatous Polyposis Treatment Market Dynamics

2.3.1 Familial Adenomatous Polyposis Treatment Industry Trends

2.3.2 Familial Adenomatous Polyposis Treatment Market Drivers

2.3.3 Familial Adenomatous Polyposis Treatment Market Challenges

2.3.4 Familial Adenomatous Polyposis Treatment Market Restraints

3.1 Global Top Familial Adenomatous Polyposis Treatment Players by Revenue

3.1.1 Global Top Familial Adenomatous Polyposis Treatment Players by Revenue (2018-2023)

3.1.2 Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Familial Adenomatous Polyposis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Familial Adenomatous Polyposis Treatment Revenue

3.4 Global Familial Adenomatous Polyposis Treatment Market Concentration Ratio

3.4.1 Global Familial Adenomatous Polyposis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Familial Adenomatous Polyposis Treatment Revenue in 2022

3.5 Familial Adenomatous Polyposis Treatment Key Players Head office and Area Served

3.6 Key Players Familial Adenomatous Polyposis Treatment Product Solution and Service

3.7 Date of Enter into Familial Adenomatous Polyposis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Familial Adenomatous Polyposis Treatment Historic Market Size by Type (2018-2023)

4.2 Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Familial Adenomatous Polyposis Treatment Historic Market Size by Application (2018-2023)

5.2 Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Familial Adenomatous Polyposis Treatment Market Size (2018-2029)

6.2 North America Familial Adenomatous Polyposis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023)

6.4 North America Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Familial Adenomatous Polyposis Treatment Market Size (2018-2029)

7.2 Europe Familial Adenomatous Polyposis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023)

7.4 Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size (2018-2029)

8.2 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Familial Adenomatous Polyposis Treatment Market Size (2018-2029)

9.2 Latin America Familial Adenomatous Polyposis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023)

9.4 Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size (2018-2029)

10.2 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Cancer Prevention Pharmaceuticals Inc

11.1.1 Cancer Prevention Pharmaceuticals Inc Company Detail

11.1.2 Cancer Prevention Pharmaceuticals Inc Business Overview

11.1.3 Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Introduction

11.1.4 Cancer Prevention Pharmaceuticals Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2018-2023)

11.1.5 Cancer Prevention Pharmaceuticals Inc Recent Development

11.2 Marina Biotech Inc

11.2.1 Marina Biotech Inc Company Detail

11.2.2 Marina Biotech Inc Business Overview

11.2.3 Marina Biotech Inc Familial Adenomatous Polyposis Treatment Introduction

11.2.4 Marina Biotech Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2018-2023)

11.2.5 Marina Biotech Inc Recent Development

11.3 Thetis Pharmaceuticals LLC

11.3.1 Thetis Pharmaceuticals LLC Company Detail

11.3.2 Thetis Pharmaceuticals LLC Business Overview

11.3.3 Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Introduction

11.3.4 Thetis Pharmaceuticals LLC Revenue in Familial Adenomatous Polyposis Treatment Business (2018-2023)

11.3.5 Thetis Pharmaceuticals LLC Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Icosapent

    Table 3. Key Players of Eflornithine Hydrochloride

    Table 4. Key Players of Aspirin

    Table 5. Key Players of CEQ-508

    Table 6. Key Players of Others

    Table 7. Global Familial Adenomatous Polyposis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Familial Adenomatous Polyposis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Familial Adenomatous Polyposis Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Familial Adenomatous Polyposis Treatment Market Share by Region (2018-2023)

    Table 11. Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Familial Adenomatous Polyposis Treatment Market Share by Region (2024-2029)

    Table 13. Familial Adenomatous Polyposis Treatment Market Trends

    Table 14. Familial Adenomatous Polyposis Treatment Market Drivers

    Table 15. Familial Adenomatous Polyposis Treatment Market Challenges

    Table 16. Familial Adenomatous Polyposis Treatment Market Restraints

    Table 17. Global Familial Adenomatous Polyposis Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Familial Adenomatous Polyposis Treatment Market Share by Players (2018-2023)

    Table 19. Global Top Familial Adenomatous Polyposis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Adenomatous Polyposis Treatment as of 2022)

    Table 20. Ranking of Global Top Familial Adenomatous Polyposis Treatment Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Familial Adenomatous Polyposis Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Familial Adenomatous Polyposis Treatment Product Solution and Service

    Table 24. Date of Enter into Familial Adenomatous Polyposis Treatment Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Familial Adenomatous Polyposis Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Type (2018-2023)

    Table 28. Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Type (2024-2029)

    Table 30. Global Familial Adenomatous Polyposis Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Application (2018-2023)

    Table 32. Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Application (2024-2029)

    Table 34. North America Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Cancer Prevention Pharmaceuticals Inc Company Detail

    Table 50. Cancer Prevention Pharmaceuticals Inc Business Overview

    Table 51. Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Product

    Table 52. Cancer Prevention Pharmaceuticals Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2018-2023) & (US$ Million)

    Table 53. Cancer Prevention Pharmaceuticals Inc Recent Development

    Table 54. Marina Biotech Inc Company Detail

    Table 55. Marina Biotech Inc Business Overview

    Table 56. Marina Biotech Inc Familial Adenomatous Polyposis Treatment Product

    Table 57. Marina Biotech Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2018-2023) & (US$ Million)

    Table 58. Marina Biotech Inc Recent Development

    Table 59. Thetis Pharmaceuticals LLC Company Detail

    Table 60. Thetis Pharmaceuticals LLC Business Overview

    Table 61. Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Product

    Table 62. Thetis Pharmaceuticals LLC Revenue in Familial Adenomatous Polyposis Treatment Business (2018-2023) & (US$ Million)

    Table 63. Thetis Pharmaceuticals LLC Recent Development

    Table 64. Research Programs/Design for This Report

    Table 65. Key Data Information from Secondary Sources

    Table 66. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Familial Adenomatous Polyposis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Familial Adenomatous Polyposis Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Icosapent Features

    Figure 4. Eflornithine Hydrochloride Features

    Figure 5. Aspirin Features

    Figure 6. CEQ-508 Features

    Figure 7. Others Features

    Figure 8. Global Familial Adenomatous Polyposis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Familial Adenomatous Polyposis Treatment Market Share by Application: 2022 VS 2029

    Figure 10. Clinic Case Studies

    Figure 11. Hospital Case Studies

    Figure 12. Others Case Studies

    Figure 13. Familial Adenomatous Polyposis Treatment Report Years Considered

    Figure 14. Global Familial Adenomatous Polyposis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Familial Adenomatous Polyposis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Familial Adenomatous Polyposis Treatment Market Share by Region: 2022 VS 2029

    Figure 17. Global Familial Adenomatous Polyposis Treatment Market Share by Players in 2022

    Figure 18. Global Top Familial Adenomatous Polyposis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Adenomatous Polyposis Treatment as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Familial Adenomatous Polyposis Treatment Revenue in 2022

    Figure 20. North America Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Familial Adenomatous Polyposis Treatment Market Share by Country (2018-2029)

    Figure 22. United States Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Familial Adenomatous Polyposis Treatment Market Share by Country (2018-2029)

    Figure 26. Germany Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Share by Region (2018-2029)

    Figure 34. China Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Familial Adenomatous Polyposis Treatment Market Share by Country (2018-2029)

    Figure 42. Mexico Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Share by Country (2018-2029)

    Figure 46. Turkey Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Cancer Prevention Pharmaceuticals Inc Revenue Growth Rate in Familial Adenomatous Polyposis Treatment Business (2018-2023)

    Figure 49. Marina Biotech Inc Revenue Growth Rate in Familial Adenomatous Polyposis Treatment Business (2018-2023)

    Figure 50. Thetis Pharmaceuticals LLC Revenue Growth Rate in Familial Adenomatous Polyposis Treatment Business (2018-2023)

    Figure 51. Bottom-up and Top-down Approaches for This Report

    Figure 52. Data Triangulation

    Figure 53. Key Executives Interviewed